Cargando…
High Seroprevalence of Anti-SARS-CoV-2 Antibodies Among Ethiopian Healthcare Workers
BACKGROUND: COVID-19 pandemic has a devastating impact on the economies and health care system of sub-Saharan Africa. Healthcare workers (HWs), the main actors of the health system, are at higher-risk because of their occupation. Serology-based estimates of SARS-CoV-2 infection among HWs represent a...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Journal Experts
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312903/ https://www.ncbi.nlm.nih.gov/pubmed/34312618 http://dx.doi.org/10.21203/rs.3.rs-676935/v1 |
_version_ | 1783729221384798208 |
---|---|
author | Gelanew, Tesfaye Seyoum, Berhanu Mulu, Andargachew Mihret, Adane Abebe, Markos Wassie, Liya Gelaw, Baye Sorsa, Abebe Merid, Yared Muchie, Yilkal Teklemariam, Zelalem Tesfaye, Bezalem Osman, Mahlet Jebessa, Gutema Atinafu, Abay Hailu, Tsegaye Habte, Antenehe. Kenea, Dagaga Gadissa, Anteneh Admasu, Desalegn Tesfaye, Emmet Bates, Timothy A. Bulcha, Jote Tschopp, Rea Tsehay, Dareskedar Mullholand, Kim Howe, Rawleigh Genetu, Abebe Tafesse, Fikadu G. Abdissa, Alemseged |
author_facet | Gelanew, Tesfaye Seyoum, Berhanu Mulu, Andargachew Mihret, Adane Abebe, Markos Wassie, Liya Gelaw, Baye Sorsa, Abebe Merid, Yared Muchie, Yilkal Teklemariam, Zelalem Tesfaye, Bezalem Osman, Mahlet Jebessa, Gutema Atinafu, Abay Hailu, Tsegaye Habte, Antenehe. Kenea, Dagaga Gadissa, Anteneh Admasu, Desalegn Tesfaye, Emmet Bates, Timothy A. Bulcha, Jote Tschopp, Rea Tsehay, Dareskedar Mullholand, Kim Howe, Rawleigh Genetu, Abebe Tafesse, Fikadu G. Abdissa, Alemseged |
author_sort | Gelanew, Tesfaye |
collection | PubMed |
description | BACKGROUND: COVID-19 pandemic has a devastating impact on the economies and health care system of sub-Saharan Africa. Healthcare workers (HWs), the main actors of the health system, are at higher-risk because of their occupation. Serology-based estimates of SARS-CoV-2 infection among HWs represent a measure of HWs’ exposure to the virus and a guide to the prevalence of SARS-CoV-2 in the community. This information is currently lacking in Ethiopia and other African countries. This study aimed to develop an in-house antibody testing assay, assess the prevalence of SARS-CoV-2 antibodies among Ethiopian high-risk frontline HWs. METHODS: A cross-sectional seroprevalence study was conducted among HWs in five public hospitals located in different geographic regions of Ethiopia. Socio-demographic and clinical data were collected using questionnaire-based interviews. From consenting HWs, blood samples were collected between December 2020 and February 2021, the period between the two peaks of COVID-19 in Ethiopia. The collected sera were tested using an in-house immunoglobin G (IgG) enzyme-linked immunosorbent assay (ELISA) for SARS-CoV-2 specific antibodies on sera collected from HWs. RESULTS: Of 1,997 HWs who provided a blood sample, demographic and clinical data, 50.5% were female, 74.0% had no symptoms compatible with COVID-19, and 29.0% had history of contact with suspected or confirmed patient with SARS-CoV-2 infection. The overall seroprevalence was 39.6%. The lowest (24.5%) and the highest (48.0%) seroprevalence rates were found in Hiwot Fana Specialized Hospital in Harar and ALERT Hospital in Addis Ababa, respectively. Of the 821 seropositive HWs, 224(27.3%) had history of symptoms consistent with COVID-19. A history of close contact with suspected/confirmed COVID-19 cases was strongly associated with seropositivity (Adjusted odds Ratio (AOR) =1.4, 95% CI 1.1–1.8; p=0.015). CONCLUSION: High SARS-CoV-2 seroprevalence levels were observed in the five Ethiopian hospitals. These findings highlight the significant burden of asymptomatic infection in Ethiopia, and may reflect the scale of transmission in the general population. |
format | Online Article Text |
id | pubmed-8312903 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | American Journal Experts |
record_format | MEDLINE/PubMed |
spelling | pubmed-83129032021-07-27 High Seroprevalence of Anti-SARS-CoV-2 Antibodies Among Ethiopian Healthcare Workers Gelanew, Tesfaye Seyoum, Berhanu Mulu, Andargachew Mihret, Adane Abebe, Markos Wassie, Liya Gelaw, Baye Sorsa, Abebe Merid, Yared Muchie, Yilkal Teklemariam, Zelalem Tesfaye, Bezalem Osman, Mahlet Jebessa, Gutema Atinafu, Abay Hailu, Tsegaye Habte, Antenehe. Kenea, Dagaga Gadissa, Anteneh Admasu, Desalegn Tesfaye, Emmet Bates, Timothy A. Bulcha, Jote Tschopp, Rea Tsehay, Dareskedar Mullholand, Kim Howe, Rawleigh Genetu, Abebe Tafesse, Fikadu G. Abdissa, Alemseged Res Sq Article BACKGROUND: COVID-19 pandemic has a devastating impact on the economies and health care system of sub-Saharan Africa. Healthcare workers (HWs), the main actors of the health system, are at higher-risk because of their occupation. Serology-based estimates of SARS-CoV-2 infection among HWs represent a measure of HWs’ exposure to the virus and a guide to the prevalence of SARS-CoV-2 in the community. This information is currently lacking in Ethiopia and other African countries. This study aimed to develop an in-house antibody testing assay, assess the prevalence of SARS-CoV-2 antibodies among Ethiopian high-risk frontline HWs. METHODS: A cross-sectional seroprevalence study was conducted among HWs in five public hospitals located in different geographic regions of Ethiopia. Socio-demographic and clinical data were collected using questionnaire-based interviews. From consenting HWs, blood samples were collected between December 2020 and February 2021, the period between the two peaks of COVID-19 in Ethiopia. The collected sera were tested using an in-house immunoglobin G (IgG) enzyme-linked immunosorbent assay (ELISA) for SARS-CoV-2 specific antibodies on sera collected from HWs. RESULTS: Of 1,997 HWs who provided a blood sample, demographic and clinical data, 50.5% were female, 74.0% had no symptoms compatible with COVID-19, and 29.0% had history of contact with suspected or confirmed patient with SARS-CoV-2 infection. The overall seroprevalence was 39.6%. The lowest (24.5%) and the highest (48.0%) seroprevalence rates were found in Hiwot Fana Specialized Hospital in Harar and ALERT Hospital in Addis Ababa, respectively. Of the 821 seropositive HWs, 224(27.3%) had history of symptoms consistent with COVID-19. A history of close contact with suspected/confirmed COVID-19 cases was strongly associated with seropositivity (Adjusted odds Ratio (AOR) =1.4, 95% CI 1.1–1.8; p=0.015). CONCLUSION: High SARS-CoV-2 seroprevalence levels were observed in the five Ethiopian hospitals. These findings highlight the significant burden of asymptomatic infection in Ethiopia, and may reflect the scale of transmission in the general population. American Journal Experts 2021-07-19 /pmc/articles/PMC8312903/ /pubmed/34312618 http://dx.doi.org/10.21203/rs.3.rs-676935/v1 Text en https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/) , which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. |
spellingShingle | Article Gelanew, Tesfaye Seyoum, Berhanu Mulu, Andargachew Mihret, Adane Abebe, Markos Wassie, Liya Gelaw, Baye Sorsa, Abebe Merid, Yared Muchie, Yilkal Teklemariam, Zelalem Tesfaye, Bezalem Osman, Mahlet Jebessa, Gutema Atinafu, Abay Hailu, Tsegaye Habte, Antenehe. Kenea, Dagaga Gadissa, Anteneh Admasu, Desalegn Tesfaye, Emmet Bates, Timothy A. Bulcha, Jote Tschopp, Rea Tsehay, Dareskedar Mullholand, Kim Howe, Rawleigh Genetu, Abebe Tafesse, Fikadu G. Abdissa, Alemseged High Seroprevalence of Anti-SARS-CoV-2 Antibodies Among Ethiopian Healthcare Workers |
title | High Seroprevalence of Anti-SARS-CoV-2 Antibodies Among Ethiopian Healthcare Workers |
title_full | High Seroprevalence of Anti-SARS-CoV-2 Antibodies Among Ethiopian Healthcare Workers |
title_fullStr | High Seroprevalence of Anti-SARS-CoV-2 Antibodies Among Ethiopian Healthcare Workers |
title_full_unstemmed | High Seroprevalence of Anti-SARS-CoV-2 Antibodies Among Ethiopian Healthcare Workers |
title_short | High Seroprevalence of Anti-SARS-CoV-2 Antibodies Among Ethiopian Healthcare Workers |
title_sort | high seroprevalence of anti-sars-cov-2 antibodies among ethiopian healthcare workers |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312903/ https://www.ncbi.nlm.nih.gov/pubmed/34312618 http://dx.doi.org/10.21203/rs.3.rs-676935/v1 |
work_keys_str_mv | AT gelanewtesfaye highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers AT seyoumberhanu highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers AT muluandargachew highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers AT mihretadane highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers AT abebemarkos highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers AT wassieliya highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers AT gelawbaye highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers AT sorsaabebe highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers AT meridyared highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers AT muchieyilkal highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers AT teklemariamzelalem highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers AT tesfayebezalem highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers AT osmanmahlet highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers AT jebessagutema highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers AT atinafuabay highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers AT hailutsegaye highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers AT habteantenehe highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers AT keneadagaga highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers AT gadissaanteneh highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers AT admasudesalegn highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers AT tesfayeemmet highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers AT batestimothya highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers AT bulchajote highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers AT tschopprea highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers AT tsehaydareskedar highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers AT mullholandkim highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers AT howerawleigh highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers AT genetuabebe highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers AT tafessefikadug highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers AT abdissaalemseged highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers |